Navigation Links
Gene transfer optimization
Date:3/4/2014

Lentiviruses, which belong to the family of retroviruses, are used as vectors to exchange genetic material in cells and can be used to replace a defective gene as defined by gene therapy. Increasing the efficiency of such a treatment poses a major medical challenge: the virus should specifically track the target cells, but the number of virus used should be as low as possible.

A research team led by Dr. Ines Hfig and Dr. Natasa Anastasov from the Institute of Radiation Biology (ISB) at Helmholtz Zentrum Mnchen in cooperation with Sirion Biotech GmbH in Munich and the Fraunhofer Institute in Aachen has now developed an adjuvant which enhances the effect of the virus transduction. Thus the transfer into the target cells is optimized without additional toxicity.

Surface molecules fuse viruses with target cells

The scientists equipped the viruses with additional surface molecules that facilitate the attachment of the viruses to their target cells. The surface molecules consist of a glycoprotein which is fused to an antibody fragment. This antibody fragment detects the surface receptors of specific target cells, such as EGFR+ or CD30+, and binds to these.

Higher transduction rate less virus used

"Through this specific binding to the target cell we can enhance three fold the transduction rate (transfer of the viruses into the target cells)," said research group leader Anastasov. "Thus, the transduction efficiency is improved, and at the same time fewer transfer viruses are needed."

In further studies, analog to the established system, suitable antibody fragments shall be evaluated for specific surface markers of various target cells, e.g. for bone marrow stem cells and immune cells. Gene therapy can thus be used as a treatment for specific genetic disorders (e.g. metachromatic leukodystrophy, Wiskott-Aldrich syndrome).


'/>"/>

Contact: Press Office
presse@helmholtz-muenchen.de
49-893-187-2238
Helmholtz Zentrum Mnchen - German Research Center for Environmental Health
Source:Eurekalert

Page: 1

Related biology news :

1. UCSB researcher shows microplastic transfers chemicals, impacting health
2. Solving electron transfer
3. UMass Amherst researchers reveal mechanism of novel biological electron transfer
4. PNNL recognized for transferring innovations to the marketplace
5. Digicel Launches Worlds First Biometric Identification System For International Money Transfers
6. Direct transfer of plant genes from chloroplasts into the cell nucleus
7. Scientists discover new method of proton transfer
8. A surprising new kind of proton transfer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/17/2016)... Global Market Watch: Primarily supported by ownership types; ... Academics) market is to witness a value of US$37.1 billion ... Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from ... 2014-2020. North America is not way ... Europe at 9.56% respectively. Report Focus: ...
(Date:11/14/2016)... Technology, Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), ... in challenging operating environments, announced its results for the ... a conference call to discuss these results on November ... Key Recent Accomplishments ... acquire Vislink Communication Systems. The purchase is expected to ...
(Date:6/22/2016)... June 22, 2016 On Monday, the Department ... industry to share solutions for the Biometric Exit Program. ... and Border Protection (CBP), explains that CBP intends to ... the United States , in order ... defeat imposters. Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
Breaking Biology News(10 mins):
(Date:12/7/2016)... ... , ... Kara Dwyer Dodge grew up hearing stories of the sea monster her father pulled ... a sea turtle entangled in the lines of one of his lobster pots. He freed ... no one could remember ever seeing one so large so close to shore. After a ...
(Date:12/6/2016)... ... December 06, 2016 , ... The Osteoarthritis Research Society ... Drug Administration (FDA) to consider OA as a serious disease. As an organization ... growing population of OA patients, many of whom may experience progressive disability and ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... Partners ("GPP") portfolio company, today announced it has acquired the assets of ... of Chiltern International and focuses on clinical trial drug packaging, labeling, storage, ...
(Date:12/6/2016)... 2016  SRI International has been awarded a ... National Institutes of Health,s National Institute of Allergy ... (NIAID-DAIDS) to support the manufacturing and characterization of ... Under the seven-year contract, SRI will provide a ... candidate HIV-prevention products that emerge from investigator-initiated studies ...
Breaking Biology Technology: